William Moschella - Dec 3, 2024 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Role: Chief Product & Tech Officer
Signature: /s/ Matthew Ruderman, Attorney-in-Fact
Stock symbol: DH
Transactions as of: Dec 3, 2024
Transactions value $: -$211,500
Form type: 4
Date filed: 12/5/2024, 08:55 AM
Previous filing: Nov 5, 2024
Next filing: Jan 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DH	Class A Common Stock	Sale	-$212K	-45K	-9.4%	$4.70	434K	Dec 3, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.67 to $4.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separated price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.67 to $4.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separated price within the range set forth in this footnote.